Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study aimed to follow the natural progression of retinal changes in patients with diabetes. Such information should inform decisions with regard to the screening intervals for such patients. RESEARCH DESIGN AND METHODS: An observational study was undertaken linking the data from seven diabetes retinal screening programs across the U.K. for retinal grading results between 2005 and 2012. Patients with absent or background retinopathy were followed up for progression to the end points referable retinopathy and treatable retinopathy (proliferative retinopathy). RESULTS: In total, 354,549 patients were observed for up to 4 years during which 16,196 patients progressed to referable retinopathy. Of patients with no retinopathy in either eye for two successive screening episodes at least 12 months apart, the conditions of between 0.3% (95% CI 0.3–0.8%) and 1.3% (1.0–1.6%) of patients progressed to referable retinopathy, and rates of treatable eye disease were <0.3% at 2 years. The corresponding progression rates for patients with bilateral background retinopathy in successive screening episodes were 13–29% and up to 4%, respectively, in the different programs. CONCLUSIONS: It may be possible to stratify patients for risk, according to baseline retinal criteria, into groups with low and high risk of their conditions progressing to proliferative retinopathy. Screening intervals for such diverse groups of patients could safely be modified according to their risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Artificial intelligence approaches to screening for diabetic retinopathy have progressed to the point of utility and cost-effectiveness.508–513”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [512]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,477
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,249
Photocoagulation Treatment of Proliferative Diabetic Retinopathy
(1981) · Ophthalmology · doi:10.1016/s0161-6420(81)34978-1 · Cited by 975
Photocoagulation for Diabetic Macular Edema
Aiello, L. M., & Ferris, F. L. (1987) · Archives of Ophthalmology · doi:10.1001/archopht.1987.01060090021004 · Cited by 733
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Massin, P., Bandello, F., Garweg, J. G., Hansen, L. L., Harding, S. P., Larsen, M., Mitchell, P., Sharp, D., Wolf-Schnurrbusch, U. E. K., Gekkieva, M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0493 · Cited by 720
Younis, N., Broadbent, D. M., Vora, J. P., & Harding, S. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12267-2 · Cited by 289
Aspelund, T., Þórisdóttir, Ó., Ólafsdottir, E., Gudmundsdottir, A., Einarsdóttir, A. B., Mehlsen, J., Einarsson, S., Pálsson, Ó., Einarsson, G., Bek, T., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2257-7 · Cited by 167
Jones, C. D., Greenwood, R. H., Misra, A., & Bachmann, M. O. (2012) · Diabetes Care · doi:10.2337/dc11-0943 · Cited by 150
Self-citationThomas, R. L., Dunstan, F., Luzio, S. D., Roy Chowdury, S., Hale, S. L., North, R. V., Gibbins, R. L., & Owens, D. R. (2012) · BMJ · doi:10.1136/bmj.e874 · Cited by 142
Agardh, E., & Tababat-Khani, P. (2011) · Diabetes Care · doi:10.2337/dc10-2308 · Cited by 113 · cited 3×
“,2% at 2 years (6,7), and lower for patients with newly diagnosed disease (8) and other defined groups (9).”
BackgroundGroup, U. P. D. S. (., Kohner, E. M., Stratton, I. M., Aldington, S. J., Holman, R. R., & Matthews, D. R. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00458.x · Cited by 112
Self-citationScreening Uptake in a Well-Established Diabetic Retinopathy Screening Program
Leese, G. P., Boyle, P., Feng, Z., Emslie-Smith, A., & Ellis, J. D. (2008) · Diabetes Care · doi:10.2337/dc08-1098 · Cited by 112
Self-citationBiennial eye screening in patients with diabetes without retinopathy: 10-year experience
Olafsdottir, E., & Stefansson, E. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.123810 · Cited by 105
Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme
Younis, N., Broadbent, D. M., Harding, S. P., & Vora, J. P. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01035.x · Cited by 103
A Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy
Stratton, I. M., Aldington, S. J., Taylor, D. J., Adler, A. I., & Scanlon, P. H. (2013) · Diabetes Care · doi:10.2337/dc12-0625 · Cited by 83
Self-citationon behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative, Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2928-7 · Cited by 80
Self-citationScreening intervals for diabetic retinopathy and incidence of visual loss: a systematic review
Echouffo-Tcheugui, J. B., Ali, M. K., Roglić, G., Hayward, R. A., & Narayan, K. M. V. (2013) · Diabetic Medicine · doi:10.1111/dme.12274 · Cited by 77
Philip, S., Cowie, L. M., & Olson, J. A. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.051334 · Cited by 65
Forster, A. S., Forbes, A., Dodhia, H., Connor, C., Chemin, A. D., Sivaprasad, S., Mann, S. S., & Gulliford, M. C. (2013) · Diabetologia · doi:10.1007/s00125-013-2975-0 · Cited by 49
Leese, G. P., Morris, A. D., Swaminathan, K., Petrie, J. R., Sinharay, R., Ellingford, A., Taylor, A., Jung, R. T., Newton, R. W., & Ellis, J. D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01603.x · Cited by 38
Self-citationDecline in the Cumulative Incidence of Severe Diabetic Retinopathy in Patients With Type 1 Diabetes
Kytö, J. P., Harjutsalo, V., Forsblom, C., Hietala, K., Summanen, P. A., Groop, P.-H., & on behalf of the FinnDiane Study Group (2011) · Diabetes Care · doi:10.2337/dc10-2391 · Cited by 37
Diabetic Retinopathy: More Patients, Less Laser
Vallance, J. H., Wilson, P. J., Leese, G., McAlpine, R., MacEwen, C. J., & Ellis, J. D. (2008) · Diabetes Care · doi:10.2337/dc07-1498 · Cited by 27
Self-citation
Research works printed but not linked: 1
- Leese, 2005, Implementation of national diabetes retinal screening programme is associated with a reduced referral rate to ophthalmology, 1112
Cited by
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Nderitu, P., Nunez do Rio, J. M., Webster, L., Mann, S., Cardoso, M. J., Modat, M., Hopkins, D., Bergeles, C., & Jackson, T. L. (2024) · Communications Medicine · doi:10.1038/s43856-024-00590-z · Cited by 16
Metadata
- Authors
- Leese, G. P., Stratton, I. M., Land, M., Bachmann, M. O., Jones, C., Scanlon, P., Looker, H. C., & Ferguson, B.
- Affiliations
- Ninewells Hospital (GB)
- Gloucestershire Eye Unit, Gloucester, U.K.
- Landmark Health Consulting, York, U.K.
- Norwich Medical School, Norwich, U.K.
- Norfolk and Norwich University Hospital (GB)
- University of Dundee (GB)
- Public Health England (GB)
- Corresponding author
- Leese, Graham P.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-12-18
- Volume
- 38
- Issue
- 3
- Pages
- 488-494
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2020023472
- Cited by
- 50
- References
- 26
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 1 · 2020: 10 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 8 · 2015: 4
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
- orcid.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research Repository (University of Gloucestershire) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Research Repository (University of Gloucestershire) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- NHS Diabetic Eye Screening Programme &NIHR Health Technology Assessment (10/66/01)
- Scottish Diabetes Retinal Screening programme
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, retinopathy progression, screening frequency, proliferative diabetic retinopathy, background retinopathy, risk stratification, community screening program, natural history (disease)
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Humans, Male, Mass Screening, Middle Aged, Retina, Retinal Diseases, Retrospective Studies, Time Factors, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.